TAE Life Sciences, a pioneer in advancing Boron Neutron Capture Therapy (BNCT) for cancer treatment, proudly announces it has earned the 2023 Biotech Breakthrough Award for Oncology Innovation of the Year.
Anthony
TAE Life Sciences Celebrates Collaboration Milestones and Unveils Alphabeam for in-hospital BNCT at ASTRO 2023 Annual Meeting
TAE Life Sciences, a pioneer in advancing Boron Neutron Capture Therapy (BNCT) for cancer treatment, is thrilled to announce it is bringing BNCT to this year’s annual meeting of the American Society for Radiation Oncology (ASTRO) in San Diego.
Novel Particle Therapy Whitepaper
Dramatic advances in cancer treatment have completely transformed the landscape of cancer care in the last several decades.
TAE Life Sciences Signs Biddle Sawyer to Manufacture Boronated TC220 Drug for BNCT Cancer Treatment
Rob Hill Promoted to CEO of TAE Life Sciences as Company Pursues Global Clinical Trials
Preliminary Results Show TAE Life Sciences’ TC440 Boron-Containing Drug Holds Promise for Revolutionizing Cancer Treatment Strategies
Preliminary Results Show TAE Life Sciences’ Novel Boron-Containing Drug Holds Promise for Revolutionizing Boron Neutron Capture Therapy
Leading Cancer Center in Poland Announce Plans for a New State-of-the-Art BNCT Facility
